METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONISTS COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES Read more about METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONISTS COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES China202380051444.5Filed on 2024-12-31
COMPOSITIONS AND METHODS FOR TREATING FIBROTIC AND INFLAMMATORY DISEASES Read more about COMPOSITIONS AND METHODS FOR TREATING FIBROTIC AND INFLAMMATORY DISEASES US Application 63/704,345Filed on 2024-10-07
CANNABINOID RECEPTOR MODULATING COMPOUNDS Read more about CANNABINOID RECEPTOR MODULATING COMPOUNDS European Patent23719936.9Filed on 2024-10-02
CANNABINOID RECEPTOR MODULATING COMPOUNDS Read more about CANNABINOID RECEPTOR MODULATING COMPOUNDS US Application 18/846,457Filed on 2024-09-12
CANNABINOID RECEPTOR MODULATING COMPOUNDS Read more about CANNABINOID RECEPTOR MODULATING COMPOUNDS Israel314385Filed on 2024-07-17
METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONISTS COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES Read more about METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONISTS COMPOSITIONS AND METHODS FOR THE TREATMENT OF FIBROSING PULMONARY DISEASES US Application 63/352,428Filed on 2022-06-15
SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS Read more about SULFONAMIDE DERIVATIVES AND THEIR USE AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS US Application 63/290,409Filed on 2021-12-16
CANNABINOID RECEPTOR MODULATING COMPOUNDS Read more about CANNABINOID RECEPTOR MODULATING COMPOUNDS US Application 63/319,642Filed on 2022-03-14
Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds Read more about Thiol-moeity Containing Cannabinoid Receptor Modulating Compounds US Application 63/265,225Filed on 2021-12-10
Process / Methodology To Convert Ureas / Sulfonyl Ureas To Chalcogenide Ureas / Sulfonyl Ureas Read more about Process / Methodology To Convert Ureas / Sulfonyl Ureas To Chalcogenide Ureas / Sulfonyl Ureas US Application 63/189,375Filed on 2021-05-17